The Role of Inflammatory and Nutritional Indices as a Predictive Markers in Multiple Myeloma Patients in the Egyptian Population
DOI:
https://doi.org/10.31557/APJCB.2026.11.3.747Keywords:
Multiple Myeloma; Prognosis; Inflammatory indices; CBCAbstract
Purpose: Multiple myeloma (MM) is a malignant proliferation of plasma cells which lead to a profound health affection.
Materials and Methods: 130 NDMM patients were included in this retrospective analysis. Patients’ clinico-pathological parameters, seven nutritional and inflammatory parameters were particularly noteworthy for investigation and correlation with disease stage, patient survival, and outcome.
Results: 53 patients (40.8%) were female, 77 patients (59.2%) were male, and the median patient age was 56.5 (47.8-64.0) years. High TLC count, pronounced anemia, and rouleaux development were all statistically significantly associated with R/ISS stage III (P=0.003), P=0.001), and P=0.010), respectively. Serum creatinine levels, low eGFR, elevated LDH, hypoalbuminemia, elevated phosphate, elevated B2 microglobulin were all significantly correlated with R/ISS stage III (P=0.001), (P=0.001), (P=0.001), (P=0.001), (P=0.001), and (P=0.002), (P=0.001), (P=0.001), respectively. The analysis of inflammatory and nutritional indices revealed that R/ISS stage I is linked to low NLR, high PNI index, and high AAPR (P=0.013), (P=0.021), and (P=0.027), respectively, while R/ISS stage III is linked to an elevated iP/L ratio (P=0.014). Low PLR is also linked to R/ISS stage III, however the difference was not statistically significant. Following a 21-month follow-up, the cumulative OS is 37.7%, and the median OS is 29.2 months with 95% CI (22.65-35.75). Patients with low PNI and those with high NLR have worse OS (P=0.014 and P=0.029), respectively. Cox regression Multivariate analysis showed that elevated NLR is considered an independent predictor of worse overall survival.
Conclusion: The study findings highlight the prognostic relevance of systemic inflammation and nutritional status in survival outcomes of NDMM patients.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Asian Pacific Journal of Cancer Biology

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
West Asia Organization for Cabcer Prevention retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4 (This permits anyone to copy, distribute, transmit and adapt the published work, provided the original work and source are appropriately cited).





3.jpg)





